Amedeo Smart

Free Medical Literature Service

 

Amedeo

Leukemia
  Free Subscription

Articles published in
Cancer Res
    October 2025
  1. ZWICK M, Zinkel B, Spohr C, Ruckert T, et al
    FLT3-ITD Induces CMTM6 and Enhances Immune Escape in Acute Myeloid Leukemia.
    Cancer Res. 2025 Oct 3. doi: 10.1158/0008-5472.CAN-25-0349.
    >> Share

    August 2025
  2. SU Y, Li S, Wang L, Wang Y, et al
    Loss of SETD8 Impairs Mitochondrial Homeostasis to Suppress Leukemia Stem Cell Function in t(8;21) Acute Myeloid Leukemia.
    Cancer Res. 2025 Aug 29. doi: 10.1158/0008-5472.CAN-24-3659.
    >> Share

    May 2025
  3. BAYET M, Fregona V, Bouttier M, Rouzier C, et al
    Modeling the PAX5P80R Mutation Reveals HIF2alpha Activation as a Common Feature and Therapeutic Target in B-Cell Acute Lymphoblastic Leukemia.
    Cancer Res. 2025 May 12. doi: 10.1158/0008-5472.CAN-24-1698.
    >> Share

  4. CHEN Y, He L, Ianevski A, Nader K, et al
    A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia.
    Cancer Res. 2025 May 12. doi: 10.1158/0008-5472.CAN-24-3840.
    >> Share

    April 2025
  5. HUBBARD AK, Brown DW, Liu J, Chan IC, et al
    Integration of Germline and Somatic Variation Improves Chronic Lymphocytic Leukemia Risk Stratification.
    Cancer Res. 2025 Apr 30. doi: 10.1158/0008-5472.CAN-24-4251.
    >> Share

    March 2025
  6. ZHOU M, Wu Z, Wei F, Duan C, et al
    SMYD3 Activates Fatty Acid beta-oxidation to Promote Self-Renewal of Leukemia Stem Cells.
    Cancer Res. 2025 Mar 13. doi: 10.1158/0008-5472.CAN-24-2117.
    >> Share

  7. OROFINO G, Toffalori C, Vago L
    In the Right Place and the Right State: Spatial Crosstalk and Immune State Dictate Leukemia Response to Immunotherapy.
    Cancer Res. 2025 Mar 11. doi: 10.1158/0008-5472.CAN-25-1018.
    >> Share

    December 2024
  8. CERMAKOVA K, Hodges HC
    Pharmacologic Blockade of a Pioneer Transcription Factor.
    Cancer Res. 2024;84:4124-4125.
    >> Share

  9. LIU X, Liu Y, Rao Q, Mei Y, et al
    Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Preleukemic Cells.
    Cancer Res. 2024;84:4233-4245.
    >> Share

    November 2024
  10. ZHAI F, Pan G, Xue L, Cheng C, et al
    PRDM16 Induces Methylation of FLT3 to Promote FLT3-ITD Signaling and Leukemia Progression.
    Cancer Res. 2024 Nov 4. doi: 10.1158/0008-5472.CAN-24-0577.
    >> Share

    October 2024
  11. LUO Z, Lin C, Yu C, Yuan C, et al
    Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia.
    Cancer Res. 2024 Oct 22. doi: 10.1158/0008-5472.CAN-24-1093.
    >> Share

    September 2024
  12. LUO H, Kharas MG
    Dotting Out AML by Targeting Fibrillarin.
    Cancer Res. 2024;84:2759-2760.
    >> Share

    August 2024
  13. TORRES-DIZ M, Reglero C, Falkenstein CD, Castro A, et al
    An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia.
    Cancer Res. 2024 Aug 2. doi: 10.1158/0008-5472.CAN-23-3804.
    >> Share

    July 2024
  14. SCHNEIDER C, Spaink H, Alexe G, Dharia NV, et al
    Targeting the Sodium-Potassium Pump as a Therapeutic Strategy in Acute Myeloid Leukemia.
    Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-23-3560.
    >> Share

  15. HUANG D, Yu Z, Lu H, Jiang P, et al
    Adhesion GPCR ADGRE2 Maintains Proteostasis to Promote Progression in Acute Myeloid Leukemia.
    Cancer Res. 2024;84:2090-2108.
    >> Share

    June 2024
  16. POORT VM, Hagelaar R, van Roosmalen MJ, Trabut L, et al
    Transient Differentiation-State Plasticity Occurs During Acute Lymphoblastic Leukemia Initiation.
    Cancer Res. 2024 Jun 17. doi: 10.1158/0008-5472.CAN-24-1090.
    >> Share

  17. BERTOLI RM, Chung YJ, Difilippantonio MJ, Wokasch A, et al
    The DNA methyltransferase inhibitor 5-aza-4'-thio-2'-deoxycytidine induces C>G transversions and acute lymphoid leukemia development.
    Cancer Res. 2024 Jun 4. doi: 10.1158/0008-5472.CAN-23-2785.
    >> Share

    April 2024
  18. BOET E, Sarry JE
    Targeting Metabolic Dependencies Fueling the TCA Cycle to Circumvent Therapy Resistance in Acute Myeloid Leukemia.
    Cancer Res. 2024;84:950-952.
    >> Share

    February 2024
  19. JIN P, Wang X, Jin Q, Zhang Y, et al
    Mutant U2AF1-induced mis-splicing of mRNA translation genes confers resistance to chemotherapy in acute myeloid leukemia.
    Cancer Res. 2024 Feb 28. doi: 10.1158/0008-5472.CAN-23-2543.
    >> Share

  20. LIU ZS, Sinha S, Bannister M, Song A, et al
    R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts.
    Cancer Res. 2024;84:577-597.
    >> Share

    January 2024
  21. MONTEITH AJ, Ramsey HE, Silver AJ, Brown D, et al
    Lactate utilization enables metabolic escape to confer resistance to BET inhibition in acute myeloid leukemia.
    Cancer Res. 2024 Jan 29. doi: 10.1158/0008-5472.CAN-23-0291.
    >> Share

  22. SU Y, Carter JL, Li X, Fukuda Y, et al
    The imipridone ONC213 targets alpha-ketoglutarate dehydrogenase to induce mitochondrial stress and suppress oxidative phosphorylation in acute myeloid leukemia.
    Cancer Res. 2024 Jan 24. doi: 10.1158/0008-5472.CAN-23-2659.
    >> Share

  23. RAUCCI F, Vernieri C, Di Tano M, Ligorio F, et al
    Cyclic fasting-mimicking diet plus bortezomib and rituximab is an effective treatment for chronic lymphocytic leukemia.
    Cancer Res. 2024 Jan 19. doi: 10.1158/0008-5472.CAN-23-0295.
    >> Share

  24. WANG P, Zhang Y, Xiang R, Yang J, et al
    Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib.
    Cancer Res. 2024 Jan 17. doi: 10.1158/0008-5472.CAN-23-1534.
    >> Share

    December 2023
  25. MAI S, Hodges A, Chen HM, Zhang J, et al
    LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.
    Cancer Res. 2023;83:4047-4062.
    >> Share

  26. XIA L, Liu JY, Yang MY, Zhang XH, et al
    Osimertinib covalently binds to CD34 and eliminates myeloid leukemia stem/progenitor cells.
    Cancer Res. 2023 Dec 14. doi: 10.1158/0008-5472.CAN-23-1632.
    >> Share

    October 2023
  27. MODI A, Lopez G, Conkrite KL, Su C, et al
    Integrative Genomic Analyses Identify LncRNA Regulatory Networks across Pediatric Leukemias and Solid Tumors.
    Cancer Res. 2023;83:3462-3477.
    >> Share

    September 2023
  28. ZIERHUT C
    p53 and Innate Immune Signaling in Development and Cancer: Insights from a Hematologic Model of Genome Instability.
    Cancer Res. 2023;83:2807-2808.
    >> Share

  29. DRESSEL N, Natusch L, Munz CM, Costas Ramon S, et al
    Activation of the cGAS/STING Axis in Genome-Damaged Hematopoietic Cells Does Not Impact Blood Cell Formation or Leukemogenesis.
    Cancer Res. 2023;83:2858-2872.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016